© RDB_rev1 JAMAICA PHARMACEUTICAL MARKET ANALYSIS Presented by Raphael D. Barrett

© RDB_rev1 y Analysis is provided for all Active Pharmaceutical Ingredients (API) and Illnesses covered by the NHFcard programme y The NHFcard covers 15 CNCD with just under 200 API in 1,000 presentations

© RDB_rev1 y In 2007 & 2008, NHFcard benefits accounted for 55% of the total prescription drugs market in Jamaica y For the API covered by the NHFcard, it is estimated that utilisation of these benefits typically account for 75% of their market y In 2007 & 2008, 90% of NHFcard benefits were accessed through private pharmacies

© RDB_rev1 The analysis offered presents a direct reading on two-thirds of the market for the Active Pharmaceutical Ingredient

© RDB_rev1 Reports Three types of reports are offered: y Active Pharmaceutical Ingredient y Therapeutic analysis y Market analysis Analysis is based on activity in the private retail pharmacies Data is available for the public sector – Drug Serv and RHA pharmacies

© RDB_rev1 API Reports y Provide a detailed analysis for an API y Data is provided for each presentation of the API y Analyses are presented for Quantity and Value at the retail purchase level y Analyses are presented by demographic (age) and geographic (parish) distribution

© RDB_rev1 Therapeutic Reports y Provide a detailed analysis for a chosen set of API y Data is provided for each API chosen y Analyses are presented for Quantity and Value at the retail purchase level y Analyses are presented by demographic (age) and geographic (parish) distribution

© RDB_rev1 Market Reports y Provide a detailed analysis for the Illnesses covered by the NHFcard y Data is provided for each Illness y Analyses are presented for Quantity and Value at the retail purchase level y Analyses are presented by demographic (age) and geographic (parish) distribution

© RDB_rev1 Sample Report NIFEDIPINE NHFcard ACTIVITY JANUARY - JUNE 2008 GEOGRAPHIC ANALYSIS UNIT SALES (QTY) PATIENT COST (revenue) cap 10mgtabCR 10mgtabCR 20mgtabCR 30mgtabCR 60mg TOTAL CAP 10mgtabCR 10mgtabCR 20mgtabCR 30mgtabCR 60mg TOTAL CLARENDON 2,35250,717114,6442,7491,941172,403 $25,203$622,543$1,754,400$257,252$273,432$2,932,830 HANOVER 5404,14716, ,964 $7,366$71,189$277,189$0$4,500$360,243 KSA 5,549150,809427,67714,76212,231611,028 $76,596$2,325,515$7,056,163$1,465,836$1,781,953$12,706,064 MANCHESTER 3,740109,404212,5802,3773,871331,972 $51,300$1,415,045$3,133,534$224,985$551,430$5,376,293 PORTLAND 2404,06511, ,335 $3,616$67,781$212,403$21,278$42,216$347,294 ST. ANN 4,01741,61795,2191,3351,182143,370 $50,043$646,791$1,511,990$128,016$168,800$2,505,640 ST. ELIZABETH 39034,68387,1241,6462,327126,170 $4,742$492,677$1,305,960$154,521$329,846$2,287,745 ST. JAMES 81053,83995,0901,2421,466152,447 $10,484$806,422$1,427,011$120,368$206,143$2,570,428 ST. MARY 18015,22432, ,317 $2,205$235,464$445,887$41,302$27,546$752,404 ST.CATHERINE 4,85284,193236,4997,0463,819336,409 $72,615$1,317,484$4,040,351$683,813$555,010$6,669,272 ST.THOMAS 1347,90135, ,06345,407 $1,541$121,568$528,389$64,928$153,930$870,356 TRELAWNY 05,04311, ,631 $0$82,166$203,781$0$4,254$290,202 WESTMORELAND 2,78420,44257, ,16383,098 $22,960$284,303$707,587$83,141$161,925$1,259,917 TOTALS 25,588582,0841,433,93233,35529,5922,104,551 $328,669$8,488,948$22,604,646$3,245,442$4,260,984$38,928,689 1%28%68%2%1% 22%58%8%11% DEMOGRAPHIC ANALYSIS UNIT SALES (QTY) PATIENT COST (revenue) cap 10mgtabCR 10mgtabCR 20mgtabCR 30mgtabCR 60mg TOTAL CAP 10mgtabCR 10mgtabCR 20mgtabCR 30mgtabCR 60mg TOTAL $2,228$2,010$1,308$0 $5, ,9035, ,464 $2,097$26,721$85,687$0$6,136$120, ,32038,469112,7351,2851,328155,137 $18,727$539,669$1,840,238$122,919$192,628$2,714, ,241167,034540,8088,9987,498732,579 $110,343$2,404,247$8,920,190$865,731$1,077,352$13,377, ,173233,308506,29615,29713,441778,515 $128,230$3,398,758$7,683,047$1,498,104$1,933,289$14,641, ,266132,914255,6546,9417,142407,917 $64,333$1,990,246$3,882,149$677,873$1,032,683$7,647, ,27613, ,495 $2,712$127,298$192,026$80,815$18,896$421,747 Total25,588582,0841,433,93233,35529,5922,104,551 $328,669$8,488,948$22,604,646$3,245,442$4,260,984$38,928,689 1%28%68%2%1% 22%58%8%11%

© RDB_rev1 Sample Charts

© RDB_rev1 Jamaica Pharmaceutical Market reports are for strategic and policy decision makers. The reports provide the ability to undertake a variety of market and product intelligence analyses

© RDB_rev1 Brand Performance y Market share analysis y Is the market for your product growing? y Is your product maintaining market share? y In which parishes are you being outperformed? y Competitive analysis y How are competitive API performing? y Are they growing faster than your API? y In which parishes are you being outperformed?

© RDB_rev1 Product Performance y Therapeutic Market analysis y Is the market for this Therapeutic category growing? y Is your API maintaining market share? y How are competitive API performing? y In which parishes are you being outperformed? y Are they growing faster than your API?

© RDB_rev1 Market Performance y Chronic Disease Market analysis y What are Jamaican patients spending their prescription dollar on? y What is the market size for a CNCD? Where is it – parish? Who is it – age? y Is there an opportunity to introduce new products to the Jamaican market?

© RDB_rev1 Competitive Analysis We have a product not listed with the NHFcard but is used in conjunction with a condition and medications covered by the NHFcard y What is the market for the NHFcard medication with which my product is used y Is my product performing as well as the that medication? y Where - parish

© RDB_rev1 Additional analyses customised for your products can be prepared and presentations done for management and marketing retreats/workshops and sales meetings